Peter Radovich

PRESIDENT AND COO

Peter Radovich (PRESIDENT AND COO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $1.5M of MIRM (16,515 sh × $91.98, as filed), executed Mar 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.3M

shares × price, as filed

Last traded

Mar 16

Filed Mar 17

Median ADV $83.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

MIRM

Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 8 sells 8 filings

Recent filings

MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.5M
16,515 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $272K
2,631 sh × $103.30
Exec Feb 2
Filed Feb 3 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $302K
3,143 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $222K
2,382 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $348K
7,879 sh × $44.21
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $623K
13,681 sh × $45.57
Exec Mar 4 2025
Filed Mar 5 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $127K
2,627 sh × $48.22
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $152K
3,177 sh × $47.92
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET